Navigation Links
ShangPharma Corporation to Hold 2011 Annual General Meeting on October 14, 2011

SHANGHAI, Aug. 24, 2011 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: SHP) ("ShangPharma" or the "Company"), a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that it will hold its 2011 annual general meeting of shareholders at 42nd Floor, Edinburgh Tower, The Landmark, 15 Queen's Road, Central, Hong Kong on October 14, 2011 at 10:00 AM (Hong Kong time). Holders of ordinary shares of the Company whose names are on the register of members of the Company at the close of business on September 6, 2011 are entitled to receive notice of, and to attend and vote at, the annual general meeting or any adjournment or postponement thereof. Holders of the Company's American Depositary Shares ("ADSs") who wish to exercise their voting rights for the underlying ordinary shares must act through the depositary of the Company's ADS program, JPMorgan Chase Bank, N.A.

The notice of the annual general meeting, which sets forth the resolutions to be submitted to shareholders for approval at the meeting, is available on the Investor Relations section of the company's website at ShangPharma has filed its annual report on Form 20-F, including its audited financial statements for the fiscal year ended December 31, 2010, with the U.S. Securities and Exchange Commission. ShangPharma's Form 20-F can be accessed on the above-mentioned website, as well as on the SEC's website at

Shareholders may request a hard copy of the company's annual report, free of charge, by contacting ShangPharma Corporation, No. 5 Building, 998 Halei Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai, 201203, People's Republic of China, telephone: +86 21 5132-0088, email:

About ShangPharma CorporationShangPharma Corporation (NYSE: SHP) is a leading China-based contract research organization providing high quality and cost-effective services for the pharmaceutical and biotechnology industry. It offers a broad range of high-quality, integrated services across the drug discovery and development process to help international and Chinese pharmaceutical and biotechnology companies discover and develop novel drug candidates efficiently. ShangPharma's services consist of discovery chemistry, discovery biology and preclinical development, pharmaceutical development and biologics services. For more information, please visit further information, please contact: ShangPharma Corporation In Shanghai, China Lan Xie VP of Finance and Investor Relations E-mail: Christensen In New York, US Kimberly Minarovich, +1 917-533-3268 In Hong Kong Tip Fleming, +852-9212-0684

SOURCE ShangPharma Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ShangPharma Announces Up to $10 Million Share Repurchase Program
2. ShangPharmas Biologics Division Announces Accelerated Achievement of Milestones for Two Multi-Stage Projects
3. ShangPharma Corporation to Announce First Quarter 2011 Financial Results on May 19, 2011
4. ShangPharma Corporation Files 2010 Annual Report on Form 20-F
5. ShangPharma Announces Fourth Quarter and Fiscal Year 2010 Results
6. ShangPharma to Present at the Citibank Global Health Care Conference from March 1 - 3, 2011
7. ShangPharma Announces Appointment of Benson Tsang as a Member of the Board of Directors and Audit Committee
8. TRXs Data Intelligence Solution, TRAVELTRAX, Helps Fortune 500 Corporations Gain New Insights Into Cost Savings
9. CVS Caremark Corporation Announces Receipt of Requisite Consents, Termination of Replacement Capital Covenant and Expiration of Consent Solicitation Relating to its 6.125% Senior Notes due August 15, 2016 (CUSIP NO. 126650BE9)
10. China Medicine Corporation Dismisses Frazer Frost as Auditor
11. Double Eagle Holdings Chooses National Securities Corporation as Exclusive Investment Banker
Post Your Comments:
(Date:11/24/2015)... , Nueva York , 24 ... Devices (ABD), fabricante del Avery Breathing Pacemaker System, ... Jonzon , MD; Ph.D. como consultor clínico. ...   --> Foto - ... El doctor Jonzon es un fisiólogo y ...
(Date:11/24/2015)... India , November 24, 2015 ... market research report "Spine Biologics Market by Product Type (Bone ... (Anterior Cervical Discectomy and Fusion, Posterior Lumbar Interbody Fusion), End ... MarketsandMarkets, the global market was valued at $1.90 Billion in ... at a CAGR of 4.4% during the forecast period of ...
(Date:11/24/2015)... , Nov. 24, 2015   HeartWare International, ... of less-invasive, miniaturized circulatory support technologies that are revolutionizing ... President and Chief Executive Officer Doug Godshall ... th Annual Healthcare Conference on December 1, 2015 ... December 1-2 in New York . ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... SCOTTSDALE, AZ) - ... surgeon specializing in both surgical and non-surgical treatments, announced the expansion of his ... Facial Plastic Surgery. , Highly trained and nationally recognized for his natural ...
(Date:11/25/2015)... ... November 25, 2015 , ... Brillianteen, McGaw YMCA’s student-produced musical ... its 65th Anniversary Brillianteen Revue, scheduled for March 4-6, 2016. Auditions for this ... Brillianteen has been a treasured tradition for numerous families in the Evanston community. ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... “While riding ... an inventor, from Bronx, N.Y. “I thought there had to be a convenient and ... the PROTECTOR. , The PROTECTOR enables disabled individuals to safely travel during cold or ...
(Date:11/25/2015)... ST. LOUIS, Missouri (PRWEB) , ... November 25, ... ... with Project HEAL, will provide scholarships for people struggling with eating disorders as ... Proceeds from the second annual event, held at Fox Run Golf Club ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... I found that regular bras were incredibly uncomfortable," said an inventor from Bronx, ... bra." , She developed the patent-pending RECOVERY BRA for added comfort and support. ...
Breaking Medicine News(10 mins):